Trial Search Results

A Study to Establish a New Onset Diabetes Cohort

Create a large biobank of blood samples and data from subjects with new onset diabetes (NOD).

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Mayo Clinic

Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Stanford Investigator(s):

Eligibility


Inclusion Criteria:

   - Must have at least (1) Parameter of Diabetes Mellitus in the past 90 days;

      - Fasting Blood Glucose (FBG) Greater than 126mg/dl

      - Hemoglobin A1c (HbA1c) Greater than 6.5%

      - Random Blood Glucose (RBG) Greater than 200mg/dl

      - 2h Post Glucose (PG) Greater than 200mg

Exclusion Criteria:

   - Patient has had Diabetes Mellitus for great than 90 days

   - No glycemic parameters (fasting glucose, HbA1c) measured and available for review in
   past 18 months

   - On active treatment for cancer, current diagnosis of any cancer, past history of
   pancreatic cancer

   - Currently taking chronic or acute oral steroids

Ages Eligible for Study

50 Years - 85 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Walter Park, MD
650-723-4102
Recruiting